Bicara Therapeutics BCAX Shows Modest Gains as Biotech Sector Eyes Key Resistance Levels Taiwans Lai Reaffirms Sovereignty Stance Announces Expanded Drone Defense Budget PPL Corporation Corporate Units PPLC Gains 16 Approaches Key Resistance Level Novartis AG NVS Stock Consolidating at 15045 Next Move Ahead 20260520 SRXH Q2 2025 Earnings EPS Loss of 074 and No Revenue Reported Weigh on Sentiment Sidus Space SIDU Q1 2026 Earnings Net Loss Per Share of 008 as Stock Surges 2397 QNRX Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment ProKidney Corp PROK Q1 2026 Earnings Narrowed Loss and Steady Progress in Kidney Disease Therapy VRTX Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick